Valuation: Celltrion, Inc.

Market Cap 48,657B 36.27B 33.03B 30.44B 27.69B 51.94B 3,359B 54.59B 370B 147B 1,834B 136B 133B 5,757B P/E 2026 *
36.3x
P/E 2027 * 26.8x
Enterprise Value 51.2B 38.16M 34.76M 32.03M 29.13M 54.65M 3.53B 57.44M 390M 155M 1.93B 143M 140M 6.06B EV / Sales 2026 *
8.88x
EV / Sales 2027 * 7.61x
Free-Float
58.03%
Yield 2026 *
0.36%
Yield 2027 * 0.38%
1 day-0.93%
1 week-0.47%
Current month+11.17%
1 month+7.79%
3 months+10.76%
6 months+17.96%
Current year+23.56%
1 week 206,500
Extreme 206500
219,000
1 month 187,500
Extreme 187500
219,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 137,362.64
Extreme 137362.63736
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 51 13/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/1/26 Sell 500 0.0002%
16/1/26 Sell 1,000 0.0004%
16/1/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-0.47%+19.34%+41.83% 36.27B
-2.49%-3.76%+53.38%+62.10% 63.66B
-0.63%-2.91%+6.55%+89.34% 58.56B
-2.37%-2.22%+21.77%+84.58% 54.19B
-2.19%-6.15%+12.43%+111.40% 44.66B
-1.89%-7.28%+9.30%+18.50% 40.51B
+1.11%-6.44%+127.46%+675.37% 34.87B
-0.80%+0.61%+76.27%+61.80% 32.26B
-2.17%+16.65%-28.89%+479.93% 31.01B
-6.57%-12.37%+34.03%-15.63% 21.45B
Average -1.89%-2.33%+33.16%+160.92% 42B
Weighted average by Cap. -1.74%-2.39%+31.94%+146.36%

Financials

2026 *2027 *
Net sales 5,768B 4.3B 3.92B 3.61B 3.28B 6.16B 398B 6.47B 43.91B 17.45B 217B 16.13B 15.79B 682B 6,625B 4.94B 4.5B 4.14B 3.77B 7.07B 457B 7.43B 50.44B 20.05B 250B 18.53B 18.14B 784B
Net income 1,358B 1.01B 922M 850M 773M 1.45B 93.74B 1.52B 10.34B 4.11B 51.2B 3.8B 3.72B 161B 1,836B 1.37B 1.25B 1.15B 1.04B 1.96B 127B 2.06B 13.98B 5.55B 69.21B 5.13B 5.03B 217B
Net Debt 2,539B 1.89B 1.72B 1.59B 1.44B 2.71B 175B 2.85B 19.33B 7.68B 95.72B 7.1B 6.95B 300B 1,760B 1.31B 1.19B 1.1B 1B 1.88B 121B 1.97B 13.4B 5.33B 66.35B 4.92B 4.82B 208B
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
20/11/26 ₩213,000.00 -0.93% 588,339
19/11/26 ₩215,000.00 +3.61% 503,358
18/11/26 ₩207,500.00 -2.58% 437,448
17/11/26 ₩213,000.00 -0.70% 350,466
16/11/26 ₩214,500.00 +0.23% 352,775
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
213,000.00KRW
Average target price
279,000.00KRW
Spread / Average Target
+30.99%
  1. Stock Market
  2. Stocks
  3. A068270 Stock